Sökning: id:"swepub:oai:lup.lub.lu.se:1af7bc56-69d0-40ce-8230-5e548cd04751" >
High-Target Hemodia...
High-Target Hemodiafiltration Convective Dose Achieved in Most Patients in a 6-Month Intermediary Analysis of the CONVINCE Randomized Controlled Trial
-
- Vernooij, Robin W.M. (författare)
- University Medical Center Utrecht
-
- Hockham, C. (författare)
- Imperial College London
-
Barth, C. (författare)
-
visa fler...
-
- Canaud, B. (författare)
- University of Montpellier
-
- Cromm, K. (författare)
- Fresenius Medical Care Deutschland GmbH
-
- Davenport, A. (författare)
- University College London
-
- Hegbrant, J. (författare)
- Lund University,Lunds universitet,Njurmedicin,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Nephrology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine
-
- Rose, M. (författare)
- Charité - University Medicine Berlin,Berlin Institute of Health (BIH)
-
- Strippoli, G. F.M. (författare)
- University of Bari Aldo Moro,University of Sydney
-
Török, M. (författare)
-
- Woodward, M. (författare)
- University of New South Wales,Imperial College London
-
- Bots, M. L. (författare)
- University Medical Center Utrecht
-
- Blankestijn, P. J. (författare)
- University Medical Center Utrecht
-
visa färre...
-
(creator_code:org_t)
- 2023
- 2023
- Engelska 8 s.
-
Ingår i: Kidney International Reports. - 2468-0249. ; 8:11, s. 2276-2283
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Introduction: High convection volumes in hemodiafiltration (HDF) result in improved survival; however, it remains unclear whether it is achievable in all patients. Methods: CONVINCE, a randomized controlled trial, randomized patients with end-stage kidney disease 1:1 to high-dose HDF versus high-flux hemodialysis (HD) continuation. We evaluated the proportion of patients achieving high-dose HDF target: convection volume per visit of ≥23 l (range ±1 l) at baseline, month 3, and month 6. We compared baseline characteristics in the following 2 ways: (i) patients on target for all 3 visits versus patients who missed target on ≥1 visits and (ii) patients on target for all 3 visits or missing it once versus patients who missed target on ≥2 visits. Results: A total of 653 patients were randomized to HDF. Their mean age was 62.2 (SD 13.5) years, 36% were female, 81% had fistula vascular access, and 33% had diabetes. Across the 3 visits, 75 patients (11%), 27 patients (4%), and 11 patients (2%) missed the convection volume target once, twice, and thrice, respectively. Apart from diabetes, there were no apparent differences in patient characteristics between patients who always achieved the high-dose target (83%) and those who missed the target either once or more (17%) or twice or more (6%). Conclusion: Achieving high-dose HDF is feasible for nearly all patients in CONVINCE and could be maintained during the 6-month follow-up period. Apart from diabetes, there were no other indications for confounding by indication on multivariable analyses that may explain the potential survival advantage for patients receiving high-dose HDF.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Urology and Nephrology (hsv//eng)
Nyckelord
- baseline characteristics
- convection volume
- hemodiafiltration
- hemodialysis
- kidney failure
- randomized controlled trial
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Vernooij, Robin ...
-
Hockham, C.
-
Barth, C.
-
Canaud, B.
-
Cromm, K.
-
Davenport, A.
-
visa fler...
-
Hegbrant, J.
-
Rose, M.
-
Strippoli, G. F. ...
-
Török, M.
-
Woodward, M.
-
Bots, M. L.
-
Blankestijn, P. ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Urologi och njur ...
- Artiklar i publikationen
-
Kidney Internati ...
- Av lärosätet
-
Lunds universitet